Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bayer AG | 18 | 5 | 1 | 4 | €27.90 | €45.00 | 61.319% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 0 | 0 | €1,072.0 | €1,091.9 | 1.858% |
| Exact Sciences | 17 | 0 | 0 | 0 | €55.82 | €75.89 | 35.957% |
| Johnson & Johnson | 39 | 1 | 0 | 0 | €150.02 | €179.00 | 19.317% |
| Roche Holding AG ADR | 3 | 3 | 0 | 0 | €38.23 | €38.00 | -0.599% |
| Novo Nordisk A/S ADR | 23 | 1 | 1 | 0 | €126.00 | €146.66 | 16.394% |
| Elanco Animal Health Inc. | 8 | 2 | 0 | 0 | €13.99 | €16.17 | 15.563% |
| Teva Pharmaceutical Industries Ltd ADR | 19 | 0 | 0 | 0 | €17.10 | €19.34 | 13.093% |
| Amgen Inc. | 28 | 0 | 0 | 0 | €301.95 | €304.82 | 0.950% |
| Biogen Inc. | 51 | 2 | 0 | 0 | €185.20 | €284.87 | 53.817% |
| GSK plc ADR | 6 | 0 | 0 | 0 | €39.80 | €49.33 | 23.937% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €101.80 | €109.00 | 7.073% |
| Pfizer Inc. | 31 | 4 | 1 | 0 | €26.24 | €41.47 | 58.079% |
| Gilead Sciences Inc | 12 | 1 | 0 | 0 | €71.46 | €84.81 | 18.685% |
| AbbVie Inc. | 34 | 0 | 0 | 0 | €177.58 | €181.45 | 2.178% |
| Merck KGaA | 5 | 1 | 0 | 0 | €175.95 | €172.00 | -2.245% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €109.50 | €112.40 | 2.646% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €125.00 | €130.00 | 4.000% |
| Eli Lilly Corp. | 68 | 0 | 2 | 0 | €867.80 | €883.50 | 1.809% |
| Sanofi S.A. ADR | 8 | 0 | 1 | 0 | €51.00 | €55.25 | 8.341% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €157.85 | €165.00 | 4.530% |
| Merck & Co. Inc. | 32 | 1 | 1 | 0 | €107.20 | €125.91 | 17.451% |
| Novo Nordisk A/S | 6 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Abbott Laboratories | 20 | 0 | 0 | 0 | €102.48 | €116.25 | 13.434% |
| UCB S.A. | 1 | 0 | 0 | 0 | €164.35 | - | - |